Back to Search Start Over

The Lost or Absence of MRD<0.1% at Any Time after 2 Cycles of Consolidation Chemotherapy in CBFB-MYH11-Positive Acute Myeloid Leukemia Indicates Poor Prognosis

Authors :
Duan, Wenbing
Jia, Jinsong
Wang, Jing
Liu, Xiaohong
Gong, Lizhong
Jiang, Qian
Zhao, Ting
Wang, Yu
Zhang, Xiaohui
Xu, Lanping
Liu, Yanrong
Qin, Yazhen
Huang, Xiaojun
Jiang, Hao
Source :
Blood; November 2019, Vol. 134 Issue: 1, Number 1 Supplement 1 p2616-2616, 1p
Publication Year :
2019

Abstract

Objective:To investigate the long-term prognostic factors of CBFB-MYH11-positive acute myeloid leukemia in low、 intermediate risk patients.

Details

Language :
English
ISSN :
00064971 and 15280020
Volume :
134
Issue :
1, Number 1 Supplement 1
Database :
Supplemental Index
Journal :
Blood
Publication Type :
Periodical
Accession number :
ejs56888262
Full Text :
https://doi.org/10.1182/blood-2019-126938